Catalent
CTLT
#1815
Rank
C$16.42 B
Marketcap
C$90.48
Share price
0.00%
Change (1 day)
15.82%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): C-$8.56

According to Catalent's latest financial reports the company's current EPS (TTM) is C-$9.02. In 2023 the company made an earnings per share (EPS) of C-$9.69 a decrease over its 2022 EPS that were of C$3.24.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)C-$8.56-11.71%
2023C-$9.69-399.56%
2022C$3.24-30.58%
2021C$4.6679.67%
2020C$2.59114.12%
2019C$1.21-15%
2018C$1.4375.44%
2017C$0.81-22.97%
2016C$1.05-59.56%
2015C$2.61282.05%
2014C$0.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
C-$2.74-69.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
C$21.74-340.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
C-$1.07-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
C-$2.11-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA